RECEIVE 25% OFF PUBLISHED ANTIBODIES WITH CODE "PUB25"! Offer valid for US customers and available internationally through distributors.

Contact us at 1.800.501.7654 or info@biossusa.com

MenuSearch

Recombinant Proteins

Recombinant Proteins

Our recombinant proteins are engineered for high purity, exceptional batch-to-batch reproducibility, and seamless scalability. Available in a wide range of tag formats including His-tag, Fc-tag, GST-tag, Avi-tag, and tag-free options, they deliver verified purity and solubility for a broad range of research applications.

Explore our catalog of 8900+ recombinant proteins and spend less time sourcing reagents and more time advancing your discoveries.



×

Collection Menu
Human CD86\/B7-2 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Human CD86\/B7-2 is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-47026P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Human CD79b on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%.
The purity of Human CD79b is greater than 95% as determined by SEC-HPLC.
Immobilized Human CD79B,His Tag at 0.5\u03bcg\/ml (100\u03bcl\/Well). Dose response curve for Anti-CD79b Ab. with the EC50 of 15.3ng\/ml determined by ELISA.
Immobilized Human CD79b, His Tag at 0.5\u03bcg\/ml (100\u03bcl\/Well). Dose response curve for Anti-CD79b Ab. with the EC50 of 15.9\/15.3\/15.2ng\/ml determined by ELISA.

Catalog #1: bs-47069P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Recombinant Human CD7 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant Human CD7 Protein is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-47068P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Catalog #1: bs-47065P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Recombinant Human CD40 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant Human CD40 Protein is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-47062P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Recombinant Human CD30 Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant Human CD30 Protein is greater than 95% as determined by SEC-HPLC.
Immobilized Human CD30,His Tag at 0.2ug\/ml(100ul\/Well). Dose response curve for Anti-CD30 Ab. with the EC50 of 9.7ng\/ml determined by ELISA.

Catalog #1: bs-47057P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Catalog #1: bs-47198P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Human CD122\/IL2RB on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Human CD122\/IL2RB is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-47044P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Recombinant BCMA on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of BCMA is greater than 95% as determined by SEC-HPLC.
Immobilized Human BCMA,His Tag at 0.5ug\/ml (100ul\/Well). Dose response curve for Human BAFF,Fc Tag with the EC50 of 18.2 ng\/ml determined by ELISA.

Catalog #1: bs-47037P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Human Angiopoietin-like 3 \/ ANGPTL3 on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%.
Immobilized Human Angiopoietin-like3,His Tag at 0.5\u03bcg\/ml (100\u03bcl\/Well). Dose response curve for Anti-ANGPTL3 Ab. with the EC50 of 12.2ng\/ml determined by ELISA.

Catalog #1: bs-47022P

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Catalog #1: bs-47023p-1mg

Applications: ELISA

Reactivity: Others

Conjugate: Unconjugated

Catalog #1: bs-48027P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48026P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48025P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48023P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48022p-10ug

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48018P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48021P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48020p-10ug

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48019P

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-48003p-50ug

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Catalog #1: bs-43045p-100ug

Applications: WB, ELISA

Reactivity: Human

Conjugate: Unconjugated

Catalog #1: bs-43044p-100ug

Applications: WB, ELISA

Reactivity: Human

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (WT), mFc Tag (Cat: bs-43046P), the EC50 is 34ng\/ml.

Catalog #1: bs-43046p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (L452Q, F490S), His Tag (Cat: bs-43051P), the EC50 is 39ng\/ml.

Catalog #1: bs-43051p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (L452Q, F490S), His Tag (Cat: bs-43052P), the EC50 is 74ng\/ml.

Catalog #1: bs-43052p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (K417T, E484K, N501Y), His Tag (Cat: bs-41454P), the EC50 is 26.96ng\/ml.

Catalog #1: bs-41454p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (L452R, E484Q), His Tag (Cat: bs-43039P), the EC50 is 165ng\/ml.

Catalog #1: bs-43039p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.\r\n
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (L452R), His Tag (Cat: bs-41458P), the EC50 is 5.24ng\/ml.

Catalog #1: bs-41458p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (Y453F), His Tag (Cat: bs-41450P), the EC50 is 8.34ng\/ml.\r\n

Catalog #1: bs-41450p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.\r\n
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2\u03bcg\/ml (100ul\/Well) can bind SARS-CoV-2 Spike RBD (K417N, E484K, N501Y), His Tag (Cat: bs-41449P), the EC50 is 15.63ng\/ml.\r\n

Catalog #1: bs-41449p-1mg

Applications: ELISA, SDS-PAGE

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-41407p-1mg

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-46108p-100ug

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-41405p-1mg

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-41409p-1mg

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-41408p-1mg

Applications: WB, ELISA

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-41410p-1mg

Applications: WB, ELISA

Reactivity: Human

Conjugate: Unconjugated

Catalog #1: bs-46110p-100ug

Applications: WB, ELISA

Reactivity: Human

Conjugate: Unconjugated

Recombinant 2019-nCoV S protein RBD on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of 2019-nCoV S protein RBD is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-46016P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-COV-2 Spike S Trimer (D614G) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-COV-2 Spike S Trimer (D614G) Protein is greater than 95% as determined by SEC-HPLC.
Immobilized SARS-COV-2 Spike S (D614G) Trimer, His Tag at 1ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 0.1ug\/ml determined by ELISA.

Catalog #1: bs-46014P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

SARS-CoV-2 Spike S1 (N501Y) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-COV-2 Spike S1 (N501Y) Protein is greater than 95% as determined by SEC-HPLC.\r\n
Immobilized SARS-CoV-2 Spike S1 (N501Y) Protein, His Tag at 0.5ug\/ml (100ul\/Well). Dose-response curve for ACE2, Fc tag with the EC50 of 80.3ng\/ml determined by ELISA.

Catalog #1: bs-46012P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike S1 (D614G) Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Recombinant SARS-CoV-2 Spike S1 (D614G) Protein is greater than 95% as determined by SEC-HPLC.
Immobilized SARS-CoV-2 Spike S1 (D614G) at 2ug\/ml (100ul\/Well). Dose-response curve for Human ACE2, Fc tag with the EC50 of 42ng\/ml determined by ELISA.

Catalog #1: bs-46010P

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Recombinant SARS-CoV-2 Spike RBD protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of SARS-CoV-2 Spike RBD is greater than 95% as determined by SEC-HPLC.\r\n
Immobilized SARS-CoV-2 RBD proteins at 0.5ug\/ml (100ul\/Well). Dose response curve for Human ACE2, with the EC50 of 18.7 ng\/ml determined by ELISA.

Catalog #1: bs-46009p-100ug

Applications: WB, ELISA, HPLC

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Catalog #1: bs-48024P-20ug

Applications: ELISA

Reactivity:

Conjugate: Unconjugated

Recombinant Human ACE2 protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of human ACE2 is greater than 95% as determined by SEC-HPLC.

Catalog #1: bs-46015P

Applications: WB, ELISA, HPLC

Reactivity: Human

Conjugate: Unconjugated